Chronic opioid use emerging after bariatric surgery

Pharmacoepidemiology and Drug Safety

Volumn 23, Issue 12, 2014, Pages 1247-1257

  Raebel, Marsha A ^a,b   Newcomer, Sophia R ^a   Bayliss, Elizabeth A ^a,c   Boudreau, Denise ^d   Debar, Lynn ^e   Elliott, Thomas E ^f,j   Ahmed, Ameena T ^g   Pawloski, Pamala A ^f   Fisher, David ^g   Toh, Sengwee ^h   Donahoo, William Troy ^c,i  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d GROUP HEALTH RESEARCH INSTITUTE   (United States)

^e CENTER FOR HEALTH RESEARCH   (United States)

^f Health Partners Institute for Education and Research   (United States)

^g KAISER PERMANENTE MEDICAL CENTER   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ University of Colorado Health Sciences Center   (United States)

^j ESSENTIA INSTITUTE OF RURAL HEALTH   (United States)

more..

Author keywords

Bariatric surgery; Chronic opioid use; Chronic pain; Obesity; Opiate; Opioid; Pharmacoepidemiology

Indexed keywords

ANALGESIC AGENT; ANXIOLYTIC AGENT; MORPHINE; OPIATE; NARCOTIC ANALGESIC AGENT;

ADULT; AGE; ARTICLE; BARIATRIC SURGERY; CHRONIC DRUG ADMINISTRATION; CHRONIC PAIN; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TOBACCO; ADVERSE EFFECTS; MIDDLE AGED; OPIOID-RELATED DISORDERS; PAIN; RISK; RISK FACTOR; TRENDS;

ANALGESICS, OPIOID; BARIATRIC SURGERY; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; OPIOID-RELATED DISORDERS; PAIN; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84914124602     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3625     Document Type: Article

References (54)

1. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307: 491-497.
2. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA 2012; 307: 483-490.
3. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013; 309: 71-82.
4. Boudreau D, Von Korff M, Rutter CM, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf 2009; 18: 1166-1175.
5. Braden JB, Fan M-Y, Edlund MJ, Martin BC, DeVries A, Sullivan MD. Trends in use of opioids by noncancer pain type 2000-2005 among Arkansas Medicaid and HealthCore enrollees: results from the TROUP study. J Pain 2008; 9: 1026-1035.
6. Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med 2011; 171: 686-691.
7. Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med 2010; 152: 85-92.
8. Braden JB, Russo J, Fan M-Y, et al. Emergency department visits among recipients of chronic opioid therapy. Arch Intern Med 2010; 170: 1425-1432.
9. Fischer B, Jones W, Rehm J. High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005-2009. Pharmacoepidemiol Drug Saf 2013; 22: 438-442.
10. Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA 2013; 309: 657-659.
11. Raebel MA, Newcomer SR, Reifler LM, et al. Chronic use of opioid medication before and after bariatric surgery. JAMA 2013; 310: 1369-1376.
12. Martell BA, O'Connor PG, Kerns RD, et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 2007; 146: 116-127.
13. Noble M, Treadwell JR, Tregear SJ, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010; 1: CD006605. DOI: 10.1002/14651858.CD006605.pub2
14. Campbell CI, Weisner C, LeResche L, et al. Age and gender trends in long-term opioid analgesic use for noncancer pain. Am J Public Health 2010; 100: 2541-2547.
15. Von Korff M, Saunders K, Ray GT, et al. De facto long-term opioid therapy for noncancer pain. Clin J Pain 2008; 24: 521-527.
16. NIH Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research. http://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-001.html. 2013. [3 September 2013].
17. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005; 43: 1130-1139.
18. Woodrow KM, Friedman GD, Siegelaub AB, Collen MF. Pain tolerance: differences according to age, sex, and race. Psychosom Med 1972; 34: 548-562.
19. Mainous AS, III, Johnson SP, Saxena SK, Wright RU. Inpatient bariatric surgery among eligible black and white men and women in the United States, 1999-2010. Am J Gastroenterol 2013; 108: 1218-1223.
20. Diatchenko L, Slade GD, Nackley AG, et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 2005; 14: 135-143.
21. Liebschutz JM, Saitz R, Weiss RD, et al. Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain. J Pain 2010; 11: 1047-1055.
22. Hooper MM, Stellato TA, Hallowell PT, et al. Musculoskeletal findings in obese subjects before and after weight loss following bariatric surgery. Int J Obes (Lond) 2007; 31: 114-120.
23. Anandacoomarasamy A, Caterson I, Sambrook P, et al. The impact of obesity on the musculoskeletal system. Int J Obes (Lond) 2008; 32: 211-222.
24. Heuch I, Hagen K, Heuch I, Ygaard O, Zwart J-A. The impact of body mass index on the prevalence of low back pain: the HUNT study. Spine 2010; 35: 764-768.
25. Shiri R, Karppinen J, Leino-Arjas P, Solovieva S, Viikari-Juntura E. The association between obesity and low back pain: a meta-analysis. Am J Epidemiol 2010; 171: 135-154.
26. Webb R, Brammah T, Lunt M, Urwin M, Allison T, Symmons D. Prevalence and predictors of intense, chronic, and disabling neck and back pain in the UK general population. Spine 2003; 28: 1195-1202.
27. Butterworth PA, Landorf KB, Smith SE, Menz HB. The association between body mass index and musculoskeletal foot disorders: a systematic review. Obesity Rev 2012; 13: 630-642.
28. Ursini F, Naty S, Grembiale RD. Fibromyalgia and obesity: the hidden link. Rheumatol Int 2011; 31: 1403-1408.
29. Greenberg I, Sogg S, Perna F. Behavioral and psychological care in weight loss surgery: best practice update. Obesity 2009; 17: 880-884.
30. Kalarchian MA, Marcus MD, Levine MD, et al. Psychiatric disorders among bariatric surgery candidates: relationship to obesity and functional health status. Am J Psychiatry 2007; 164: 328-334.
31. Wadden TA, Butryn ML, Sarwer DB, et al. Comparison of psychosocial status in treatment-seeking women with class III vs. class I-II obesity. Obesity (Silver Spring) 2006; 14: S90-S98.
32. Mitchell JE, Selzer F, Kalarchian MA, et al. Psychopathology before surgery in the Longitudinal Assessment of Bariatric Surgery-3 (LABS-3) psychosocial study. Surg Obes Rel Dis 2012; 8: 533-541.
33. Chou R, Fanciullo GJ, Fine PG, Miaskowski C, Passik SD, Portenoy RK. Opioids for chronic noncancer pain: prediction and identification of aberrant drug related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009; 10: 131-146.
34. Simon GE, Von Korff M, Barlow W, et al. Predictors of chronic benzodiazepine use in a health maintenance organization sample. J Clin Epidemiol 1996; 49: 1067-1073.
35. Stein K, Kopf A. Anesthesia and treatment of chronic pain. In Miller's Anesthesia (7th edn), Miller RD, Eriksson LI, Fleisher LA, Weiher-Kronish JP, Young WL (eds). Churchill Livingstone: Maryland Heights, MO, 2009; 1797-1818.
36. Lynch ME, Watson CP. The pharmacotherapy of chronic pain: a review. Pain Res Manage 2006; 11: 11-38.
37. Rathmell JP, Fields HL. Chapter 11. Pain: pathophysiology and management. In Harrison's Principles of Internal Medicine (18th edn), Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson L, Loscalzo J (eds). McGraw-Hill, 2012. http://www.accessmedicine.com/content.aspx?aID=9094544. 2013. [22 September 2013].
38. Hosmer DW, Lemeshow S. Applied Logistic Regression. John Wiley and Sons: New York, 1989.
39. Allison PD. Logistic Regression Using the SAS System: Theory and Application. SAS Institute: Cary, NC, 1999.
40. Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain 2010; 150: 573-581.
41. Chang G, Chen L, Mao J. Opioid tolerance and hyperalgesia. Med Clin N Am 2007; 91: 199-211.
42. Chu LF, Clark D, Angst MS. Molecular basis and clinical implications of opioid tolerance and opioid-induced hyperalgesia. In Acute Pain Management. Cambridge University Press: New York, 2009; 114-146.
43. Dodet P, Perrot S, Auvergne L, et al. Sensory impairment in obese patients? Sensitivity and pain detection thresholds for electrical stimulation after surgery-induced weight loss, and comparison with a non-obese population. Clin J Pain 2012; 29: 43-49.
44. Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient-2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Endocr Pract 2013; 19: 337-372.
45. Linares CL, Decleves X, Oppert J-M, et al. Pharmacology of morphine in obese patients: clinical implications. Clin Pharmacokinet 2009; 48: 635-651.
46. Sullivan MD, Edlund MJ, Fan MY, DeVries A, Brennan Braden J, Martin BC. Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: the TROUP study. Pain 2010; 150: 332-339.
47. Bascarino JA, Rukstalis M, Hoffman SN, et al. Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction 2010; 105: 1776-1782.
48. Hojsted J, Ekholm O, Kurita GP, Juel K, Sjogren P. Addictive behaviors related to opioid use for chronic pain: a population-based study. Pain 2013; 154(12): 2677-2683. DOI:10.1016/j.pain.2013.07.046.
49. National Institute on Drug Abuse. Research Report Series. Prescription Drugs: Abuse and Addiction. http://www.drugabuse.gov/sites/default/files/rrprescription.pdf. 2011. [26 September 2013].
50. Longitudinal Assessment of Bariatric Surgery (LABS) Consortium, Flum DR, Belle SH, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009; 361: 445-454.
51. Korenkov M, Shah S, Sauerland S, Duenschede F, Junginger T. Impact of laparoscopic adjustable gastric banding on obesity co-morbidities in the medium- and long-term. Obes Surg 2007; 17: 679-683.
52. Josbeno DA, Jakicic JM, Hergenroeder A, Eid GM. Physical activity and physical function changes in obese individuals after gastric bypass surgery. Surg Obes Rel Dis 2010; 6: 361-366.
53. Khoueir P, Black MH, Crookes PF, Kaurman HS, Katkhouda N, Wang MY. Prospective assessment of axial back pain symptoms before and after bariatric weight reduction surgery. Spine 2009; 9: 454-463.
54. Saber AA, Boros MJ, Mancl T, Elgamal MH, Song S, Wisadrattanapong T. The effect of laparoscopic Roux-en-Y gastric bypass on fibromyalgia. Obes Surg 2008; 18: 652-655.